S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Neuropace, Inc. Common Stock

NPCE XNAS
$18.35 -0.94 (-4.87%) ▼ 15-min delayed
Open
$19.50
High
$19.60
Low
$18.32
Volume
329.2K
Market Cap
$622.99M

About Neuropace, Inc. Common Stock

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 209 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $99.99M $-21,465,000 $-0.66
FY 2025 $99.99M $-21,465,000 $-0.66
Q3 2025 $27.35M $-3,496,000 $-0.11
Q2 2025 $23.52M $-8,651,000 $-0.26

Related Market News

No specific coverage for NPCE yet. Check out our latest market news or earnings calendar.

Get NPCE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Neuropace, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.